Symbols / SXTC Stock $2.09 +0.00% China SXT Pharmaceuticals, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • China • NCM
SXTC (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Feng Zhou
Exch · Country NCM · China
Market Cap 2.00M
Enterprise Value -18.48M
Income -8.87M
Sales 1.54M
FCF (ttm) -1.95M
Book/sh 26.16
Cash/sh 27.55
Employees 75
Insider 10d —
IPO Jan 04, 2019
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S 1.30
P/B 0.08
P/C —
EV/EBITDA 2.22
EV/Sales -12.02
Quick Ratio 4.04
Current Ratio 4.37
Debt/Eq 5.95
LT Debt/Eq —
EPS (ttm) -57.15
EPS next Y —
EPS Growth —
Revenue Growth -24.50%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA -18.27%
ROE -50.30%
ROIC —
Gross Margin 21.74%
Oper. Margin -10.12%
Profit Margin 0.00%
Shs Outstand 958.08K
Shs Float 702.05K
Insider Own 9.24%
Instit Own 0.07%
Short Float 0.96%
Short Ratio 0.10
Short Interest 9.22K
52W High 1,047.00
vs 52W High -99.80%
52W Low 1.25
vs 52W Low 67.20%
Beta 1.75
Impl. Vol. —
Rel Volume 0.01
Avg Volume 255.62K
Volume 2.26K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $2.09
Price $2.09
Change 0.00%
About

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$2.08
Latest analyst target
3. DCF / Fair value
$-36.61
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.08
Low
—
High
—
Mean
—
News
RSS: Latest SXTC news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Revenue
1.74
-9.73%
1.93
-2.19%
1.97
-24.23%
2.60
Operating Revenue
1.74
-9.73%
1.93
-2.19%
1.97
-24.23%
2.60
Cost Of Revenue
1.37
-0.08%
1.37
-11.06%
1.55
+14.42%
1.35
Reconciled Cost Of Revenue
1.37
-0.08%
1.37
-11.06%
1.55
+14.42%
1.35
Gross Profit
0.37
-33.67%
0.55
+29.96%
0.43
-65.94%
1.25
Operating Expense
3.05
-0.69%
3.07
-49.13%
6.03
-6.33%
6.44
Selling General And Administration
3.05
-0.69%
3.07
-49.13%
6.03
-6.33%
6.44
Selling And Marketing Expense
0.29
-33.15%
0.43
+11.90%
0.39
-58.09%
0.92
General And Administrative Expense
2.76
+4.65%
2.64
-53.32%
5.65
+2.35%
5.52
Other Gand A
2.76
+4.65%
2.64
-53.32%
5.65
+2.35%
5.52
Total Expenses
4.42
-0.50%
4.44
-41.37%
7.58
-2.73%
7.79
Operating Income
-2.68
-6.57%
-2.52
+55.15%
-5.61
-8.05%
-5.19
Total Operating Income As Reported
-2.68
-6.57%
-2.52
+55.15%
-5.61
-8.05%
-5.19
EBITDA
-2.57
-9.45%
-2.35
+54.86%
-5.21
-3.10%
-5.05
Normalized EBITDA
-2.57
-9.45%
-2.35
+54.86%
-5.21
-3.10%
-5.05
Reconciled Depreciation
0.08
-59.51%
0.20
-18.75%
0.25
-21.83%
0.32
EBIT
-2.66
-3.96%
-2.55
+53.20%
-5.46
-1.61%
-5.37
Total Unusual Items
—
—
—
0.00
Total Unusual Items Excluding Goodwill
—
—
—
0.00
Special Income Charges
—
—
—
0.00
Net Income
-3.30
-6.62%
-3.10
+47.79%
-5.93
-3.46%
-5.74
Pretax Income
-3.30
-6.62%
-3.10
+47.79%
-5.93
-9.74%
-5.41
Net Non Operating Interest Income Expense
-0.65
-19.10%
-0.54
-14.16%
-0.48
-1199.29%
-0.04
Interest Expense Non Operating
0.65
+19.10%
0.54
+14.16%
0.48
+1199.29%
0.04
Net Interest Income
-0.65
-19.10%
-0.54
-14.16%
-0.48
-1199.29%
-0.04
Interest Expense
0.65
+19.10%
0.54
+14.16%
0.48
+1199.29%
0.04
Other Income Expense
0.03
+164.17%
-0.04
-126.11%
0.15
+182.34%
-0.18
Other Non Operating Income Expenses
0.03
+164.17%
-0.04
-126.11%
0.15
+182.34%
-0.18
Tax Provision
0.00
0.00
0.00
-100.00%
0.33
Tax Rate For Calcs
0.00
0.00
0.00
-100.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-3.30
-6.62%
-3.10
+47.79%
-5.93
-3.46%
-5.74
Net Income From Continuing Operation Net Minority Interest
-3.30
-6.62%
-3.10
+47.79%
-5.93
-3.46%
-5.74
Net Income From Continuing And Discontinued Operation
-3.30
-6.62%
-3.10
+47.79%
-5.93
-3.46%
-5.74
Net Income Continuous Operations
-3.30
-6.62%
-3.10
+47.79%
-5.93
-3.46%
-5.74
Normalized Income
-3.30
-6.62%
-3.10
+47.79%
-5.93
-3.46%
-5.74
Net Income Common Stockholders
-3.30
-6.62%
-3.10
+47.79%
-5.93
-3.46%
-5.74
Diluted EPS
-348.15
+79.24%
-1,676.69
+89.24%
-15,576.83
+81.81%
-85,613.36
Basic EPS
-348.15
+79.24%
-1,676.69
+89.24%
-15,576.83
+81.81%
-85,613.36
Basic Average Shares
0.01
+413.42%
0.00
+385.04%
0.00
+468.66%
0.00
Diluted Average Shares
0.01
+413.42%
0.00
+385.04%
0.00
+468.66%
0.00
Diluted NI Availto Com Stockholders
-3.30
-6.62%
-3.10
+47.79%
-5.93
-3.46%
-5.74
Total Other Finance Cost
—
—
0.48
+1199.29%
0.04
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Assets
21.66
-6.33%
23.13
-21.75%
29.55
-11.90%
33.55
Current Assets
21.30
+49.62%
14.23
-27.09%
19.52
-13.05%
22.45
Cash Cash Equivalents And Short Term Investments
18.10
+49.95%
12.07
-30.50%
17.37
+11.88%
15.52
Cash And Cash Equivalents
18.10
+49.95%
12.07
-30.50%
17.37
+11.88%
15.52
Receivables
1.90
+41.13%
1.35
-14.52%
1.58
-72.91%
5.81
Accounts Receivable
1.30
-1.02%
1.31
-2.22%
1.34
-59.66%
3.33
Gross Accounts Receivable
3.38
+11.08%
3.05
+6.24%
2.87
-30.00%
4.10
Allowance For Doubtful Accounts Receivable
-2.08
-20.27%
-1.73
-13.71%
-1.52
-99.57%
-0.76
Receivables Adjustments Allowances
-0.47
+0.50%
-0.47
+0.92%
-0.47
0.00
Other Receivables
0.52
+4.51%
0.50
-22.46%
0.65
-23.98%
0.85
Accrued Interest Receivable
—
—
0.00
-100.00%
0.08
Loans Receivable
0.12
0.00
0.00
-100.00%
1.50
Inventory
0.83
+4.18%
0.79
+49.62%
0.53
-47.79%
1.02
Raw Materials
0.44
+35.88%
0.32
+31.86%
0.24
-59.79%
0.60
Finished Goods
0.45
-18.97%
0.55
+23.90%
0.45
-23.58%
0.58
Prepaid Assets
0.44
+2844.93%
0.01
-67.82%
0.05
-7.97%
0.05
Current Deferred Assets
—
—
—
0.00
Restricted Cash
0.03
+344.50%
0.01
0.00
-100.00%
0.05
Other Current Assets
—
—
—
0.29
Total Non Current Assets
0.37
-95.87%
8.89
-11.35%
10.03
-9.57%
11.09
Net PPE
0.36
-37.10%
0.56
-55.48%
1.27
-20.28%
1.59
Gross PPE
2.94
-4.84%
3.09
-4.67%
3.25
-4.87%
3.41
Accumulated Depreciation
-2.59
-2.36%
-2.53
-27.91%
-1.98
-8.60%
-1.82
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
0.34
-0.50%
0.34
-4.88%
0.36
0.00
Machinery Furniture Equipment
0.90
-13.98%
1.05
-4.24%
1.09
-1.32%
1.11
Construction In Progress
—
—
0.00
-100.00%
0.36
Other Properties
0.14
-0.50%
0.14
-4.88%
0.15
-7.69%
0.16
Leases
1.56
-0.07%
1.56
-4.88%
1.64
-7.69%
1.78
Goodwill And Other Intangible Assets
0.01
-38.18%
0.02
-31.46%
0.03
-28.10%
0.04
Other Intangible Assets
0.01
-38.18%
0.02
-31.46%
0.03
-28.10%
0.04
Non Current Deferred Assets
—
—
—
0.00
Non Current Deferred Taxes Assets
—
—
—
0.00
Non Current Prepaid Assets
0.00
-100.00%
8.31
-4.88%
8.74
-7.69%
9.46
Total Liabilities Net Minority Interest
6.22
-32.33%
9.20
-38.12%
14.86
-13.19%
17.12
Current Liabilities
6.01
-32.46%
8.90
-38.59%
14.50
-15.33%
17.12
Payables And Accrued Expenses
4.45
-23.04%
5.79
-42.36%
10.04
-32.51%
14.88
Payables
3.35
-26.56%
4.56
-49.83%
9.09
-35.20%
14.03
Accounts Payable
1.16
-9.47%
1.28
-7.14%
1.38
-7.04%
1.48
Other Payable
1.16
-1.81%
1.18
-15.87%
1.40
-47.69%
2.68
Current Accrued Expenses
1.10
-9.96%
1.23
+29.14%
0.95
+12.12%
0.85
Total Tax Payable
1.03
-2.00%
1.05
-4.74%
1.10
-5.38%
1.17
Current Debt And Capital Lease Obligation
0.77
-67.18%
2.35
-30.61%
3.39
+65.70%
2.05
Current Debt
0.71
-69.01%
2.29
-31.15%
3.33
+62.87%
2.05
Other Current Borrowings
0.71
-69.01%
2.29
-31.15%
3.33
+62.87%
2.05
Current Capital Lease Obligation
0.06
+5.01%
0.06
+0.38%
0.06
0.00
Current Deferred Liabilities
0.06
-68.76%
0.19
+13.37%
0.17
+113.96%
0.08
Current Deferred Revenue
0.06
-68.76%
0.19
+13.37%
0.17
+113.96%
0.08
Other Current Liabilities
0.67
+86.53%
0.36
-54.19%
0.79
-32.10%
1.16
Total Non Current Liabilities Net Minority Interest
0.21
-28.16%
0.29
-19.45%
0.37
0.00
Long Term Debt And Capital Lease Obligation
0.21
-28.16%
0.29
-19.45%
0.37
0.00
Long Term Debt
0.10
-17.81%
0.12
-0.62%
0.12
—
Long Term Capital Lease Obligation
0.12
-34.99%
0.18
-28.40%
0.25
0.00
Stockholders Equity
15.44
+10.83%
13.93
-5.18%
14.69
-10.55%
16.42
Common Stock Equity
15.44
+10.83%
13.93
-5.18%
14.69
-10.55%
16.42
Capital Stock
44.53
+923.15%
4.35
+376.29%
0.91
+462.44%
0.16
Common Stock
44.53
+923.15%
4.35
+376.29%
0.91
+462.44%
0.16
Share Issued
0.09
+4865.10%
0.00
+385.04%
0.00
+468.66%
0.00
Ordinary Shares Number
0.09
+4865.10%
0.00
+385.04%
0.00
+468.66%
0.00
Additional Paid In Capital
0.00
-100.00%
35.32
-0.77%
35.59
+14.82%
30.99
Retained Earnings
-28.02
-13.37%
-24.71
-14.34%
-21.61
-37.77%
-15.69
Gains Losses Not Affecting Retained Earnings
-1.08
-4.85%
-1.03
-419.20%
-0.20
-120.66%
0.96
Other Equity Adjustments
-1.08
-4.85%
-1.03
-419.20%
-0.20
-120.66%
0.96
Total Equity Gross Minority Interest
15.44
+10.83%
13.93
-5.18%
14.69
-10.55%
16.42
Total Capitalization
15.54
+10.60%
14.05
-5.14%
14.81
-9.84%
16.42
Working Capital
15.28
+186.69%
5.33
+6.11%
5.02
-5.74%
5.33
Invested Capital
16.25
-0.58%
16.34
-9.92%
18.14
-1.78%
18.47
Total Debt
0.98
-62.84%
2.65
-29.53%
3.76
+83.58%
2.05
Capital Lease Obligations
0.18
-25.10%
0.24
-22.94%
0.31
0.00
Net Tangible Assets
15.43
+10.90%
13.91
-5.13%
14.66
-10.51%
16.39
Tangible Book Value
15.43
+10.90%
13.91
-5.13%
14.66
-10.51%
16.39
Current Provisions
0.05
-74.77%
0.21
+90.77%
0.11
-8.81%
0.12
Duefrom Related Parties Current
0.42
0.00
-100.00%
0.06
+274.69%
0.02
Dueto Related Parties Current
0.00
-100.00%
1.05
-79.87%
5.20
-40.16%
8.70
Inventories Adjustments Allowances
-0.06
+29.08%
-0.08
+49.92%
-0.16
+7.69%
-0.17
Notes Receivable
—
—
0.00
-100.00%
0.04
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Cash Flow
-2.35
-21.64%
-1.93
-2287.47%
-0.08
-130.10%
0.27
Cash Flow From Continuing Operating Activities
-2.35
-21.64%
-1.93
-2287.47%
-0.08
-130.10%
0.27
Net Income From Continuing Operations
-3.30
-6.62%
-3.10
+47.79%
-5.93
-3.46%
-5.74
Depreciation Amortization Depletion
0.08
-59.51%
0.20
-18.75%
0.25
-21.83%
0.32
Depreciation
0.08
-61.66%
0.20
—
—
Amortization Cash Flow
0.01
-2.96%
0.01
—
—
Depreciation And Amortization
0.08
-59.51%
0.20
-18.75%
0.25
-21.83%
0.32
Amortization Of Intangibles
0.01
-2.96%
0.01
—
—
Other Non Cash Items
1.60
+340.22%
0.36
-11.28%
0.41
-30.51%
0.59
Stock Based Compensation
0.00
-100.00%
0.35
-36.51%
0.55
-76.24%
2.33
Provisionand Write Offof Assets
0.26
-6.80%
0.28
-90.15%
2.88
+502.49%
0.48
Asset Impairment Charge
-0.02
-106.52%
0.35
+0.42%
0.35
+554.72%
0.05
Deferred Tax
—
0.00
0.00
-100.00%
0.33
Deferred Income Tax
—
0.00
0.00
-100.00%
0.33
Operating Gains Losses
0.01
—
—
—
Gain Loss On Sale Of PPE
0.01
0.00
0.00
—
Change In Working Capital
-0.97
-154.67%
-0.38
-126.96%
1.42
-25.62%
1.90
Change In Receivables
-0.48
-169.60%
-0.18
-117.89%
1.00
+25.08%
0.80
Changes In Account Receivables
-0.26
+20.02%
-0.32
-135.21%
0.91
+9.80%
0.83
Change In Inventory
-0.01
+93.38%
-0.22
-153.71%
0.41
+326.19%
-0.18
Change In Prepaid Assets
-0.29
-1080.46%
0.03
+21172.46%
0.00
-99.99%
1.50
Change In Payables And Accrued Expense
0.17
+307.10%
-0.08
-747.65%
-0.01
-102.91%
0.33
Change In Accrued Expense
0.30
+654.96%
-0.05
-16.09%
-0.05
-112.05%
0.38
Change In Payable
-0.13
-369.17%
-0.03
-175.34%
0.04
+167.08%
-0.05
Change In Account Payable
-0.11
-289.97%
-0.03
-401.59%
0.01
+142.56%
-0.02
Change In Other Working Capital
-0.13
-523.16%
0.03
-67.73%
0.09
+150.61%
-0.19
Change In Other Current Liabilities
-0.23
-701.21%
0.04
+151.15%
-0.07
+79.38%
-0.36
Investing Cash Flow
0.06
+140.38%
0.03
+314.77%
-0.01
+73.77%
-0.05
Cash Flow From Continuing Investing Activities
0.06
+140.38%
0.03
+314.77%
-0.01
+73.77%
-0.05
Net PPE Purchase And Sale
0.06
+999.28%
-0.01
+90.01%
-0.07
-13.11%
-0.06
Purchase Of PPE
-0.00
+71.36%
-0.01
+90.01%
-0.07
-13.11%
-0.06
Sale Of PPE
0.07
0.00
0.00
—
Capital Expenditure
-0.00
+71.36%
-0.01
+90.01%
-0.07
-13.11%
-0.06
Net Investment Purchase And Sale
—
—
0.00
0.00
Purchase Of Investment
—
—
0.00
0.00
Net Intangibles Purchase And Sale
—
—
—
0.00
Purchase Of Intangibles
—
—
—
0.00
Net Other Investing Changes
—
0.03
-42.64%
0.06
+274.69%
0.02
Financing Cash Flow
8.40
+420.04%
-2.62
-189.22%
2.94
+84.41%
1.60
Cash Flow From Continuing Financing Activities
8.40
+420.04%
-2.62
-189.22%
2.94
+84.41%
1.60
Net Issuance Payments Of Debt
-0.07
-104.59%
1.42
-64.58%
4.00
+44.49%
2.77
Issuance Of Debt
1.85
+23.76%
1.50
-62.86%
4.03
+43.72%
2.80
Repayment Of Debt
-1.92
-2338.68%
-0.08
-201.29%
-0.03
+21.02%
-0.03
Long Term Debt Issuance
1.85
+23.76%
1.50
-62.86%
4.03
+43.72%
2.80
Long Term Debt Payments
-1.92
-2338.68%
-0.08
-201.29%
-0.03
+21.02%
-0.03
Net Long Term Debt Issuance
-0.07
-104.59%
1.42
-64.58%
4.00
+44.49%
2.77
Short Term Debt Issuance
—
—
3.72
+32.69%
2.80
Short Term Debt Payments
—
—
0.00
0.00
Net Short Term Debt Issuance
—
—
0.00
0.00
Net Common Stock Issuance
2.76
0.00
-100.00%
2.19
-29.54%
3.12
Proceeds From Stock Option Exercised
—
0.00
0.00
+100.00%
-0.03
Net Other Financing Charges
5.70
+241.09%
-4.04
-24.09%
-3.26
+23.55%
-4.26
Changes In Cash
6.12
+235.16%
-4.53
-258.89%
2.85
+56.81%
1.82
Effect Of Exchange Rate Changes
-0.07
+91.49%
-0.77
+27.10%
-1.05
-366.34%
0.39
Beginning Cash Position
12.08
-30.46%
17.37
+11.55%
15.57
+16.55%
13.36
End Cash Position
18.13
+50.11%
12.08
-30.46%
17.37
+11.55%
15.57
Free Cash Flow
-2.35
-21.30%
-1.94
-1177.80%
-0.15
-173.59%
0.21
Interest Paid Supplemental Data
0.02
-13.43%
0.02
+88.04%
0.01
+308.10%
0.00
Income Tax Paid Supplemental Data
—
0.00
0.00
-100.00%
0.02
Change In Income Tax Payable
-0.02
-1114.21%
0.00
-94.23%
0.03
+184.55%
-0.03
Change In Tax Payable
-0.02
-1114.21%
0.00
-94.23%
0.03
+184.55%
-0.03
Common Stock Issuance
2.76
0.00
-100.00%
2.19
-29.54%
3.12
Issuance Of Capital Stock
2.76
0.00
-100.00%
2.19
-29.54%
3.12
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category